Substituted, non-coding nucleic acid molecule for therapeutic and prophylactic stimulation of the immune system in humans and higher animals
View Patent ↗Short deoxyribonucleic acid molecules that are partially single-stranded, dumbbell shaped, and covalently closed, which contain one or more unmethylated cytosine guanosine motif (CpG motif) and exhibit immunomodifying effects. Such molecules can be used for immunostimulation applications in humans and vertebrates.
1. A non-coding nucleic acid molecule comprising;
a partially single-stranded, dumbbell-shaped covalently closed chain of deoxyribonucleotide residues and contains one or more sequences of the base sequence N 1 N 2 CGN 3 N 4 in its single or double stranded region, where CG contains an unmethylated Cytosine, where N 1 N 2 is an element chosen from the group comprising GT, GG, GA, AT or AA, N 3 N 4 is an element chosen from the group comprising CT or TT, and C is deoxycytosine, G is deoxyguanosine, A is deoxyadenosine and T is deoxythymidine, wherein one or more substituents are covalently attached to said non-coding nucleic acid molecule.
2. The deoxyribonucleic nucleic acid molecule of claim 1 , wherein the one or more substituent is selected from a group of compounds consisting of peptides, proteins, saccharides, antigenic structures, DNA and RNA.
3. The deoxyribonucleic nucleic acid molecule of claim 2 , wherein when more than one substituent is present, they may be selected from the same or different compounds.
4. The deoxyribonucleic nucleic acid molecule according to claim 3 , wherein when more than one substituent is present from the same compound they may be identical or different from each other.
5. The deoxyribonucleic nucleic acid molecule according to claim 4 , wherein the substituents and the nucleotides are chemically modified and covalently attached to each other.
6. The deoxyribonucleic nucleic acid molecule according to claim 5 , wherein the substituents and the nucleotides are attached to each other by means of a bi-functional coupling reagent.
7. The deoxyribonucleic nucleic acid molecule according to claim 6 , which contains at least one substituent with a nuclear localization signal of SEQ ID NO 6.
8. A vaccine composition for immune stimulation in humans and higher animals, comprising: a non-coding nucleic acid molecule comprising a partially single-stranded, dumbbell-shaped covalently closed chain of deoxyribonucleotide residues and contains one or more sequences of the base sequence N 1 N 2 CGN 3 N 4 in its single or double stranded region, where CG contains an unmethylated Cytosine, where N 1 N 2 is an element chosen from the group comprising GT, GG, GA, AT or AA, N 3 N 4 is an element chosen from the group comprising CT or TT, and C is deoxycytosine, G is deoxyguanosine, A is deoxyadenosine and T is deoxythymidine, wherein one or more substituents are covalently attached to said non-coding nucleic acid molecule; and a suitable carrier.
9. The deoxyribonucleic nucleic acid molecule according to claim 1 , wherein: in the case of covalent attachment of more than one substituent, these are selected from the same or different groups; and several substituents originating from the group of peptides, proteins, saccharides, antigenic structures, DNA and/or RNA are identical or different from each other.
10. The deoxyribonucleic nucleic acid molecule according to claim 1 , wherein at least one of: chemically modified substituents and/or chemically modified nucleotides are covalently attached to each other; and the deoxyribonucleic nucleic acid molecule is substituted at least once with a nuclear localization signal of SEQ ID NO 6.
11. The deoxyribonucleic nucleic acid molecule according to claim 1 , wherein: the substituent and the nucleotide are attached to each other by means of a bi-functional coupling reagent; and the deoxyribonucleic nucleic acid molecule is substituted at least once with a nuclear localization signal of SEQ ID NO 6.